Summit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.
8 reports, 6 independent
Updated Sun 00:00
No new developments lately
- Reports
- 8
- Developments
- 4
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Summit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Akeso and Summit Therapeutics partnered, and Akeso presented trial results at ESMO.1 source
Akeso and Summit conducted Phase III study in China, presenting results in Madrid.1 source
Akeso's engineering expertise is being leveraged in the development of ivonescimab.1 source
Summit seeks FDA approval for its drug, presented at ASCO, in collaboration with Akeso.1 source
Keep exploring
The entities involved
-
Summit
supermarket chain in Japan
Nothing else this week.
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
Akeso
Chinese Biopharmaceutical Company
Nothing else this week.
-
Leerink partners
U.S. investment bank
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- medicaldaily.com
- finanznachrichten.de
- yahoo.com
- yahoo.com
- manilatimes.net
- themediaonline.co.za
- biopharmadive.com